Diagnostic role of technitium-99m bone scan in severe COVID-19-associated myositis
- PMID: 34007372
- PMCID: PMC8118662
- DOI: 10.1016/j.radcr.2021.05.019
Diagnostic role of technitium-99m bone scan in severe COVID-19-associated myositis
Abstract
Coronavirus disease 2019 (COVID-19), initially appreciated as a respiratory illness, is now known to affect many organs in the human body. Significant data has become available on muscle involvement, with creatinine kinase elevations present in a significant percentage of patients. For those with suspected COVID-19-associated myositis, the imaging modality of choice has been gadolinium-enhanced magnetic resonance imaging; however, the use of technitium-99 m bone scan has not been previously reported. Here, we report two cases of COVID-19 patients with severe elevation in creatinine kinase who underwent technitium-99 m bone scan. The resulting images showed diffuse symmetrical muscle involvement. Both patients developed acute renal injury due to rhabdomyolysis. To our knowledge, this is the first report of bone scan as a diagnostic imaging modality for COVID-19-associated myositis.
Keywords: Bone scan; COVID; Myositis; Rhabdomyolysis.
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures
References
-
- Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94:959–969. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
